-
Product Insights
Muscular Dystrophy – Drugs In Development, 2023
Global Markets Direct’s, ‘Muscular Dystrophy - Drugs In Development, 2023’, provides an overview of the Muscular Dystrophy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Muscular Dystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Limb-Girdle Muscular Dystrophy – Drugs In Development, 2023
Global Markets Direct’s, ‘Limb-Girdle Muscular Dystrophy - Drugs In Development, 2023’, provides an overview of the Limb-Girdle Muscular Dystrophy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Limb-Girdle Muscular Dystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MGD-024 in Systemic Mastocytosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MGD-024 in Systemic Mastocytosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MGD-024 in Systemic Mastocytosis Drug Details:MGD-024 is under development for the treatment of...
-
Thematic Analysis
Artificial Intelligence – Executive Briefing (Second Edition) – Thematic Intelligence
The additional benefits and features of the second edition include the following: Update on the latest trends in AI such as constitutional AI, dynalang, and AI TRiSM. Review recent AI chip developments, both technological and geopolitical. Analysis of emerging delivery models, with considerations on domain-specific training and data sensitivity. Regulatory update with a focus on the EU AI Act. Updated use cases and company profiles. How is the ‘AI Executive Briefing - Second Edition’ report different from other reports in the...
-
Product Insights
Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Aesthetic Devices Pipeline Market Report Overview Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. The Aesthetic devices pipeline market research report provides comprehensive information about the aesthetic devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Aesthetic Injectables ·      ...
-
Product Insights
Hip Reconstruction Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Hip Reconstruction Pipeline Market Overview Hip reconstruction or hip replacement is a procedure that involves the replacement of the damaged or diseased parts of the hip joint. This category includes devices (implants) used in hip replacement procedures. The hip reconstruction pipeline market research report provides comprehensive information about the hip reconstruction pipeline reconstruction with a comparative analysis of the reconstruction at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Primary Hip...
-
Product Insights
Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology comprises of reagents, and test kits to detect the pathogenicity of bacteria such as chlamydia, gonococci, syphilis, helicobacter pylori, salmonella and so on. The bacteriology pipeline market research report provides comprehensive information about the bacteriology pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ribitol
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ribitol Drug Details Ribitol (BBP-418) is under development for the treatment of limb-girdle muscular...
-
Product Insights
Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscular Dystrophy Pipeline Drugs Market Report Overview Muscular dystrophy is a group of diseases in which muscle fibers are unusually susceptible to damage. These damaged muscles become progressively weaker. Symptoms usually appear before age 6 and may appear as early as infancy. They may include fatigue, learning difficulties, intellectual disability, muscle weakness, and progressive difficulty walking. The report titled ‘Muscular Dystrophy –Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update’, provides an overview of...